Pfizer and BioNTech Report Evidence That Their Vaccine Is Effective Against COVID-19 Variant

Vaccine partners Pfizer (NYSE: PFE) and BioNTech (NASDAQ: BNTX) today released information providing new evidence that their COVID-19 vaccine is effective against the B.1.1.7 variant, originally detected in the UK has been and is believed to be more contagious than the original strain of coronavirus. Pfizer and BioNTech conducted a laboratory study exposing blood serum from subjects who had received the company's BNT162b2 vaccine to pseudoviruses that carried either the spike protein of the original Wuhan strain or that of the B.1.1.7 variant . In the study, researchers tested sera from 16 subjects - eight from adults between 18 and 55 years old and eight from older subjects.

Last News

Eager to Say ‘I Told You So,’ Paul Singer Warns of Trouble Ahead

The Real World Homecoming: New York Reopens Decades-Old Wounds for the Original Cast — Watch Trailer

Rep. Al Green scolds GOP over Equality Act: ‘You used God to enslave my foreparents’

Ted Cruz responds to John Boehner reportedly telling him to ‘go f— yourself’

Amelia Hamlin Responds to Blackfishing Accusations Over Recent Instagram Pic

While Chris Webber waits for the Hall of Fame, he's helping minorities in the cannabis industry